Intraday MarketsStock report · STAA · STAAR Surgical Company · Nov 1, 2026
Intraday Markets
Home › Stocks › STAA

STAA Stock: Price, Earnings History and SEC Filings

STAAR Surgical Company (STAA) last traded at $24.54, down 2.77% on the latest session and up 8.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.18 against an analyst estimate of $0.05, a beat of 260.0%.

$24.54 -2.77%
1 month+8.54%
52-week high$35.87
52-week low$15.59
Volume535,488
ExchangeNasdaqGM

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

STAA earnings history

QuarterReportedEPSEstimateSurprise
Jun 2026Aug 12, 2026$0.18$0.05+260.00%
Mar 2026May 13, 2026$0.29$-0.03+1066.67%
Dec 2025Mar 3, 2026$-0.13$0.03-533.33%
Sep 2025Nov 5, 2025$0.30$0.05+500.00%

STAA beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.

How STAA reacts to earnings

Across its last 8 earnings releases, STAA moved 5.3% on average the next session, in either direction. It rose after 6 of 8 reports.

Report dateReleasedNext-session move
2026-08-12After close-0.31%
2026-05-13After close+8.88%
2026-03-03After close+1.59%
2025-11-05After close+5.47%
2025-10-20Before open+1.16%
2025-08-06After close+0.19%
2025-05-07After close+0.46%
2025-02-11After close-24.68%

Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.

STAA financial history

Revenue
$91M2017$124M2018$150M2020$230M2021$239M2022$322M2023$314M2024$239M2026
Net income
-$2M2017$5M2018$14M2020$28M2021$40M2022$21M2023-$20M2024-$80M2026
Free cash flow
$2M2017$11M2018$16M2020$30M2021$18M2022-$4M2023-$8M2024-$40M2026
Fiscal yearRevenueNet incomeFree cash flowNet marginDiluted EPS
2026$239M-$80M-$40M-33.6%$-1.62
2024$314M-$20M-$8M-6.4%$-0.41
2023$322M$21M-$4M6.6%$0.43
2022$239M$40M$18M16.6%$0.80
2021$230M$28M$30M11.9%$0.56
2020$150M$14M$16M9.4%$0.30
2018$124M$5M$11M4.0%$0.11
2017$91M-$2M$2M-2.4%$-0.05

Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.

Latest SEC filings for STAA

Insider filing activity

STAA insiders filed 5 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.

Source: SEC EDGAR.

STAA news

About STAAR Surgical Company

STAAR Surgical Company (STAA) is a US-listed public company on Nasdaq. The SEC classifies its business as Ophthalmic Goods. It is incorporated in DE. Its fiscal year ends in January.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed